Michael E Ivan

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, CA, USA
    J Neurooncol 121:53-61. 2015
  2. doi Placement of a subdural evacuating port system for management of iatrogenic hyperacute subdural hemorrhage following intracranial monitor placement
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94117, USA Neurosurgery Brain and Spinal Injury Center, University of California, San Francisco, San Francisco General Hospital, CA, USA Electronic address
    J Clin Neurosci 20:1767-70. 2013
  3. doi Mini supraorbital approach to inferior frontal lobe cavernous malformations: case series
    Michael E Ivan
    Department of Neurosurgery, UCSF, San Francisco, California 94143 0112, United States
    J Neurol Surg A Cent Eur Neurosurg 74:187-91. 2013
  4. pmc Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells
    Matthew Z Sun
    Corresponding Author Andrew T Parsa, MD, PhD, Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94117
    Neuro Oncol 15:1518-31. 2013
  5. pmc Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells
    Michael Safaee
    Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 10:e0111532. 2015
  6. doi Gross total resection improves overall survival in children with choroid plexus carcinoma
    Matthew Z Sun
    Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94117, USA
    J Neurooncol 116:179-85. 2014
  7. doi Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma
    Matthew Z Sun
    Department of Neurological Surgery, University of California, San Francisco, California and
    J Neurosurg 122:1144-50. 2015
  8. pmc Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients
    Michael Safaee
    Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA
    PLoS ONE 8:e62765. 2013
  9. pmc PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma
    Taemin Oh
    Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Feinberg School of Medicine, 676 N St Clair Street, Suite 2210, Chicago, IL 60611 2911, USA
    Immunotherapy 6:737-53. 2014
  10. doi Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma
    Matthew Z Sun
    Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA, 94117, USA
    J Neurooncol 120:353-60. 2014

Collaborators

Detail Information

Publications24

  1. doi Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, CA, USA
    J Neurooncol 121:53-61. 2015
    ....
  2. doi Placement of a subdural evacuating port system for management of iatrogenic hyperacute subdural hemorrhage following intracranial monitor placement
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94117, USA Neurosurgery Brain and Spinal Injury Center, University of California, San Francisco, San Francisco General Hospital, CA, USA Electronic address
    J Clin Neurosci 20:1767-70. 2013
    ..This technique should be added to the armament of treatment options for a neurosurgeon to treat or temporize a hyperacute SDH with increased intracranial pressure in specific patients. ..
  3. doi Mini supraorbital approach to inferior frontal lobe cavernous malformations: case series
    Michael E Ivan
    Department of Neurosurgery, UCSF, San Francisco, California 94143 0112, United States
    J Neurol Surg A Cent Eur Neurosurg 74:187-91. 2013
    ..Inferior frontal lobe cavernous malformations are an excellent target for this minimally invasive approach, and we present our experience with two patients...
  4. pmc Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells
    Matthew Z Sun
    Corresponding Author Andrew T Parsa, MD, PhD, Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94117
    Neuro Oncol 15:1518-31. 2013
    ....
  5. pmc Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells
    Michael Safaee
    Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 10:e0111532. 2015
    ..Given its proven roles in tumor invasion, expression among aggressive genetic subtypes of GBM, and association with overall survival, CD97 is an attractive therapeutic target for patients with GBM. ..
  6. doi Gross total resection improves overall survival in children with choroid plexus carcinoma
    Matthew Z Sun
    Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94117, USA
    J Neurooncol 116:179-85. 2014
    ..027), the effect did not meet our criteria for significance in our multivariate Cox model (p = 0.120). GTR improved OS of pediatric CPC and is recommended if it can be safely performed. ..
  7. doi Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma
    Matthew Z Sun
    Department of Neurological Surgery, University of California, San Francisco, California and
    J Neurosurg 122:1144-50. 2015
    ....
  8. pmc Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients
    Michael Safaee
    Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA
    PLoS ONE 8:e62765. 2013
    ..This phenotype may explain the discrepancy in survival between high and low CD97-expressing tumors. This data provides impetus for further studies to determine its viability as a therapeutic target in the treatment of GBM...
  9. pmc PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma
    Taemin Oh
    Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Feinberg School of Medicine, 676 N St Clair Street, Suite 2210, Chicago, IL 60611 2911, USA
    Immunotherapy 6:737-53. 2014
    ..This will help determine if these inhibitors are truly a therapeutic avenue with a strong future in GBM immunotherapy...
  10. doi Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma
    Matthew Z Sun
    Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA, 94117, USA
    J Neurooncol 120:353-60. 2014
    ..291, p = 0.027). Both chemotherapy alone and combined chemo-radiation improved OS independent of age, gender, tumor location and extent of resection, while radiation alone did not...
  11. pmc Immunocompetent murine models for the study of glioblastoma immunotherapy
    Taemin Oh
    Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, 676 N, St, Clair St, Suite 2210, Chicago, IL 60611 2922, USA
    J Transl Med 12:107. 2014
    ....
  12. doi Current management of choroid plexus carcinomas
    Matthew Z Sun
    Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94117, USA
    Neurosurg Rev 37:179-92; discussion 192. 2014
    ..In this paper we summarize the current management of CPC in the literature. Further studies are needed to standardize the treatment paradigm for this malignant brain tumor...
  13. doi CD97 is a multifunctional leukocyte receptor with distinct roles in human cancers (Review)
    Michael Safaee
    Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Int J Oncol 43:1343-50. 2013
    ..In this review, we will discuss the structure and function of this receptor, with a specific focus on its mechanistic significance in neoplastic diseases. ..
  14. pmc Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells
    Aaron J Clark
    The Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, CA 505 Parnassus Ave, Room 779 M, San Francisco, CA, 94143 0112, USA
    J Transl Med 12:345. 2014
    ..However, tumor modification for luciferase has the potential for evoking host immune response against otherwise syngeneic tumor cells, thereby mitigating the tumor cells' value for tumor immunology and immunotherapy studies...
  15. doi Facial neuroma masquerading as acoustic neuroma
    Eli T Sayegh
    Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, 676 N St Clair Street, Suite 2210, Chicago, IL 60611 2911, USA
    J Clin Neurosci 21:1817-8. 2014
    ..Clinicians should recognize the natural history, diagnostic approach, and management of this unusual and mimetic lesion...
  16. doi The limited capacity of malignant glioma-derived exosomes to suppress peripheral immune effectors
    J Bryan Iorgulescu
    Department of Neurological Surgery, UCSF, San Francisco, CA, USA Clinical and Translational Science Institute, UCSF, San Francisco, CA, USA
    J Neuroimmunol 290:103-8. 2016
    ..Our results suggest that malignant glioma-derived exosomes are restricted in their capacity to directly prime peripheral immunosuppression. ..
  17. doi Risk factors for postoperative cerebrospinal fluid leak and meningitis after expanded endoscopic endonasal surgery
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, M7, San Francisco, CA 94143 0112, USA Center for Minimally Invasive Skull Base Surgery, University of California, San Francisco, CA, USA Electronic address
    J Clin Neurosci 22:48-54. 2015
    ..Risks associated with complex surgical resections when combining open and endoscopic approaches could be minimized by staging these procedures. ..
  18. pmc Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, California
    J Neurol Surg B Skull Base 73:76-83. 2012
    ..In conclusion, complete excision of SWMs is always recommended whenever possible, but surgeons should acknowledge that there is nonetheless a chance of recurrence and should weigh this against the risk of causing cranial nerve injuries...
  19. pmc Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas
    Michael C Oh
    Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Ave, San Francisco, CA 94117, USA
    Neuro Oncol 15:208-15. 2013
    ..We performed a comprehensive review of the literature to evaluate whether adjuvant radiotherapy after subtotal resection (STR) has any benefit...
  20. doi Brainstem cavernous malformations: surgical results in 104 patients and a proposed grading system to predict neurological outcomes
    Roxanna M Garcia
    Department of Neurological Surgery, and Center for Cerebrovascular Research, University of California at San Francisco, San Francisco, California
    Neurosurgery 76:265-77; discussion 277-8. 2015
    ..Recommending surgery is a difficult decision that would be facilitated by a grading system designed specifically for BSCMs that predicted surgical outcomes...
  21. doi Intraventricular neurocytomas: a systematic review of stereotactic radiosurgery and fractionated conventional radiotherapy for residual or recurrent tumors
    Roxanna M Garcia
    University of California, Berkeley Department of Epidemiology, 101 Haviland Hall, Berkeley 94720, USA Department of Neurosurgery, University of California, San Francisco, 505 Parnassus Avenue, Room M779, San Francisco 94143 0112, USA Electronic address
    Clin Neurol Neurosurg 117:55-64. 2014
    ..5% versus 5.5%, p=0.24). The role of SRS or FCRT in the management of residual or recurrent IVNs will continue to depend on the balance between the risks and benefits of SRS and FCRT until better quality data are available. ..
  22. doi Transvenous Approach to Intracranial Arteriovenous Malformations: Challenging the Axioms of Arteriovenous Malformation Therapy?
    Omar Choudhri
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, California Department of Neurological Surgery, University of California, San Francisco, San Francisco, California
    Neurosurgery 77:644-51; discussion 652. 2015
    ..We review the current literature on transvenous AVM therapy and highlight its role for AVM therapy in the present day...
  23. doi Tumors of the anterior skull base
    Michael E Ivan
    Department of Neurological Surgery, University of California, San Francisco, CA, USAand
    Expert Rev Neurother 14:425-38. 2014
    ..Surgical resection remains the mainstay in treatment of these tumors, particularly in the hands of experienced surgeons exercising proper patient and case selection. ..
  24. doi Minimally invasive approaches to the anterior skull base
    Michael E Ivan
    Department of Neurological Surgery, University of California San Francisco, CA 94143 0112, USA
    Neurosurg Clin N Am 24:19-37. 2013
    ....